Araim Pharmaceuticals, Inc.
Biotechnology ResearchNew York, United States0-1 Employees
Araim Pharmaceuticals, Inc. is a biotechnology research company based in Tarrytown, New York, focused on therapies that repair tissue damage caused by serious diseases. Its core science centers on Innate Repair Receptors, described as a global master regulator that promotes cellular and tissue repair across diverse disease states. The company’s lead candidate, Cibinetide, is in clinical development with an emphasis on unmet needs in neuroscience and diabetes complications. It has built a library of IRR activators and has shown in vivo proof of concept for ten distinct compounds, supported by collaborations with leading academic researchers worldwide. In terms of market positioning, Araim operates within the biotechnology research field, aiming to translate repair biology into therapies for injuries and chronic diseases underserved by current treatments. A notable development in the company’s history is a strategic partnership formed in 2015 with Vault Bioventures to advance its peptide library toward market applications.